[{"type":"bedGraph","name":"H3K27me3_Karpas422_UCSC_MODIF.bed","url":"http://epigenomegateway.wustl.edu/browser/t/1914454345.txt.gz","mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":15,"summeth":1}},{"type":"bedGraph","name":"H3K27me3_Pfeiffer_UCSC_MODIF.bed","url":"http://epigenomegateway.wustl.edu/browser/t/1359802587.txt.gz","mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":15,"summeth":1}},{"type":"bedGraph","name":"H3K27me3_WSU-DLCL-2_UCSC_MODIF.bed","url":"http://epigenomegateway.wustl.edu/browser/t/343257442.txt.gz","mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":15,"summeth":1}},{"type":"categorical","name":"K562 chromatin state","url":"http://egg.wustl.edu/d/hg19/wgEncodeBroadHmmK562HMM.gz","public":true,"mode":1,"qtc":{"anglescale":1,"height":15},"annotation":["27004","14018","30003"],"categories":{"1":["Active promoter","#ff0000"],"2":["Weak promoter","#ff6969"],"3":["Inactive/poised promoter","#cf0bc6"],"4":["Strong enhancer","#faca00"],"5":["Strong enhancer","#faca00"],"6":["Weak enhancer","#fffc04"],"7":["Weak enhancer","#fffc04"],"8":["Insulator","#0abefe"],"9":["Transcriptional transition","#00b050"],"10":["Transcriptional elongation","#00b050"],"11":["Weak transcribed","#99ff66"],"12":["Polycomb-repressed","#7f7f7f"],"13":["Heterochromatin, low signal","#f5f5f5"],"14":["Repetitive/CNV","#f5f5f5"],"15":["Repetitive/CNV","#f5f5f5"],"-1":["no information","transparent"]},"details":{"lab":"Broad","dataType":"Combined","cell":"K562","dataVersion":"ENCODE Mar 2012 Freeze","geoSampleAccession":"GSM936088","softwareVersion":"ChromHMM_ENCODEDynamicsPaper","download_url":"http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHmm/wgEncodeBroadHmmK562HMM.bed.gz"},"geolst":["GSM936088"]},{"type":"bigWig","name":"USC ChipSeq K562 Input","url":"http://egg.wustl.edu/d/hg19/GSM935601_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":200,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14018","22001","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Input","antibody description":"Control signal which may be subtracted from experimental raw signal before peaks are called.","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","labversion":"Illumina 2.0, low confidence sequences excluded","original_filename":"GSM935601_hg19_wgEncodeSydhTfbsK562InputUcdSig.bigWig"},"geolst":["GSM935601"]},{"type":"bigWig","name":"UW ChipSeq K562 Input","url":"http://egg.wustl.edu/d/hg19/GSM945294_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":200,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14018","22001","30004"],"details":{"lab":"UW","lab description":"Stamatoyannopoulous - University of Washington","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Input","antibody description":"Control signal which may be subtracted from experimental raw signal before peaks are called.","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000471","labexpid":"DS11488","labversion":"Bowtie 0.12.5","replicate":"1","original_filename":"GSM945294_hg19_wgEncodeUwHistoneK562InputStdRawRep1.bigWig"},"geolst":["GSM945294"]},{"type":"bigWig","name":"Broad ChipSeq K562 EZH2","url":"http://egg.wustl.edu/d/hg19/GSM1003576_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14018","22060","30003"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"This EZH2 antibody was raised against a recombinant protein corresponding to amino acids 353-451 of human EZH2. Antibody Target: EZH2","antibody targetdescription":"EZH2 (Enhancer of Zeste homolog 2, also designated Enx1 and SETDB1) is a human homolog of the Drosophila Polycomb-group protein Enhancer of Zeste protein. It contains a SET domain that catalyzes the methylation of histone H3 at lysine 27 (Histone H3 Lys27 monomethylated, dimethylated and trimethylated). Polycomb-group proteins repress gene expression by binding to chromatin and locally altering chromatin structure. EZH2, BMI-1 and Suz12 are present in the PRC2 and PRC3 protein complexes that function as mediators of epigenetic transcriptional silencing. EZH2 associates with the embryonic ectoderm development protein, the VAV1 oncoprotein, and the X-linked nuclear protein. EZH2 may play a role in the hematopoietic and central nervous systems. Deregulation of EZH2 is linked to a variety of cancers.","antibody vendorname":"Active Motif","antibody vendorid":"39875","controlid":"K562/Input/std","replicate":"1,2","softwareversion":"ScriptureVPaperR3","cell sex":"F","antibody":"EZH2_(39875)","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","original_filename":"GSM1003576_hg19_wgEncodeBroadHistoneK562Ezh239875StdSig.bigWig"},"geolst":["GSM1003576"]},{"type":"bigWig","name":"USC ChipSeq K562 Input","url":"http://egg.wustl.edu/d/hg19/GSM788074_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":200,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14018","22001","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Input","antibody description":"Control signal which may be subtracted from experimental raw signal before peaks are called.","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","labversion":"remapped from hg18, Illumina 2.0, low confidence sequences excluded","original_filename":"GSM788074_wgEncodeSydhHistoneK562InputUcdSig.bigWig"},"geolst":["GSM788074"]},{"type":"bigWig","name":"UW ChipSeq K562 H3K4me3","url":"http://egg.wustl.edu/d/hg19/GSM945165_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":117,"pb":0,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14018","22009","30004"],"details":{"lab":"UW","lab description":"Stamatoyannopoulous - University of Washington","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"H3K4me3","antibody antibodydescription":"rabbit polyclonal. Antibody Target: H3K4me3","antibody targetdescription":"Histone H3 (tri methyl K4). Marks promoters that are active or poised to be activated.","antibody vendorname":"Millipore","antibody vendorid":"07-473","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000471","labexpid":"DS11507","labversion":"Bowtie 0.12.5","replicate":"1","original_filename":"GSM945165_hg19_wgEncodeUwHistoneK562H3k4me3StdRawRep2.bigWig"},"geolst":["GSM945165"]},{"type":"bigWig","name":"UW ChipSeq K562 H3K27me3","url":"http://egg.wustl.edu/d/hg19/GSM945228_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":180,"pg":0,"pb":0,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14018","22018","30004"],"details":{"lab":"UW","lab description":"Stamatoyannopoulous - University of Washington","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"H3K27me3","antibody antibodydescription":"rabbit polyclonal. Antibody Target: H3K27me3","antibody targetdescription":"Histone H3 (tri-methyl K27). Marks promoters that are silenced by Polycomb proteins in a given lineage","antibody vendorname":"Millipore","antibody vendorid":"07-449","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000471","labexpid":"DS12066","labversion":"Bowtie 0.12.5","replicate":"1","original_filename":"GSM945228_hg19_wgEncodeUwHistoneK562H3k27me3StdRawRep1.bigWig"},"geolst":["GSM945228"]},{"type":"bigWig","name":"K562 EZH2","url":"http://egg.wustl.edu/d/hg19/GSM830992_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14018","22060","30003"],"details":{"cell type":"K562 erythrocytic leukaemia cells (ATCC CCL-243)","chip antibody":"Active motif,39901","original_filename":"GSM830992_K562_EZH2.bw"},"geolst":["GSM830992"]},{"type":"bigWig","name":"USC ChipSeq K562 H3K27me3B","url":"http://egg.wustl.edu/d/hg19/GSM788088_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14018","22030","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"H3K27me3B","antibody antibodydescription":"rabbit monoclonal","antibody targetdescription":"Histone H3 (tri-methyl K27) marks repressed chromatin regions","antibody vendorname":"Cell Signaling","antibody vendorid":"9733S","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","replicate":"1","replicate description":"tier 1","original_filename":"GSM788088_wgEncodeSydhHistoneK562H3k27me3bUcdSig.bigWig"},"geolst":["GSM788088"]},{"type":"bigWig","name":"USC ChipSeq K562 H3K4me1","url":"http://egg.wustl.edu/d/hg19/GSM788085_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":133,"pb":66,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14018","22010","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"H3K4me1","antibody antibodydescription":"rabbit polyclonal","antibody targetdescription":"Histone H3 (mono methyl K4). Is associated with enhancers, and downstream of transcription starts.","antibody vendorname":"Abcam","antibody vendorid":"ab8895","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","replicate":"1","replicate description":"tier 1","original_filename":"GSM788085_wgEncodeSydhHistoneK562H3k4me1UcdSig.bigWig"},"geolst":["GSM788085"]},{"type":"bigWig","name":"USC ChipSeq K562 H3K4me3B","url":"http://egg.wustl.edu/d/hg19/GSM788087_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14018","22031","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"H3K4me3B","antibody antibodydescription":"Rabbit monoclonal antibody","antibody targetdescription":"Histone H3 (tri-methyl K4) marks promoters in chromatin regions","antibody vendorname":"Cell Signaling","antibody vendorid":"9751S","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","replicate":"1","replicate description":"tier 1","original_filename":"GSM788087_wgEncodeSydhHistoneK562H3k4me3bUcdSig.bigWig"},"geolst":["GSM788087"]},{"type":"bigWig","name":"Broad ChipSeq A549 Control","url":"http://egg.wustl.edu/d/hg19/GSM1003541_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":200,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14011","22000","30003"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","controlid":"A549/EtOH_0.02pct/Input/std","replicate":"1","cell":"A549","cell organism":"human","cell description":"epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male. - ATCC, newly promoted to tier 2: not in 2011 analysis","cell karyotype":"cancer","cell lineage":"endoderm","cell sex":"M","antibody":"Control","treatment":"EtOH_0.02pct","treatment description":"1 h with 0.02% Ethanol (Myers)","control":"std","control description":"Standard input signal for most experiments.","labversion":"Illumina_HiSeq_2000","labversion description":"Illumina HiSeq 2000","original_filename":"GSM1003541_hg19_wgEncodeBroadHistoneA549ControlEtoh02Sig.bigWig"},"geolst":["GSM1003541"]},{"type":"bigWig","name":"Broad ChipSeq A549 Control","url":"http://egg.wustl.edu/d/hg19/GSM1003540_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":200,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14011","22000","30003"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","controlid":"A549/DEX_100nM/Input/std","replicate":"1","cell":"A549","cell organism":"human","cell description":"epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male. - ATCC, newly promoted to tier 2: not in 2011 analysis","cell karyotype":"cancer","cell lineage":"endoderm","cell sex":"M","antibody":"Control","treatment":"DEX_100nM","treatment description":"1 h with 100 nM Dexamethasone (Myers)","control":"std","control description":"Standard input signal for most experiments.","labversion":"Illumina_HiSeq_2000","labversion description":"Illumina HiSeq 2000","original_filename":"GSM1003540_hg19_wgEncodeBroadHistoneA549ControlDex100nmSig.bigWig"},"geolst":["GSM1003540"]},{"type":"bigWig","name":"Broad ChipSeq A549 H3K4me3","url":"http://egg.wustl.edu/d/hg19/GSM1003542_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":117,"pb":0,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14011","22009","30003"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"rabbit polyclonal. Antibody Target: H3K4me3","antibody targetdescription":"Histone H3 (tri methyl K4). Marks promoters that are active or poised to be activated.","antibody vendorname":"Millipore","antibody vendorid":"07-473","controlid":"A549/DEX_100nM/Input/std","replicate":"1,2","softwareversion":"ScriptureVPaperR3","cell sex":"M","antibody":"H3K4me3","treatment":"DEX_100nM","treatment description":"1 h with 100 nM Dexamethasone (Myers)","control":"std","control description":"Standard input signal for most experiments.","labversion":"Illumina_HiSeq_2000","labversion description":"Illumina HiSeq 2000","original_filename":"GSM1003542_hg19_wgEncodeBroadHistoneA549H3k04me3Dex100nmSig.bigWig"},"geolst":["GSM1003542"]},{"type":"bigWig","name":"Broad ChipSeq A549 H3K27ac","url":"http://egg.wustl.edu/d/hg19/GSM1003578_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":150,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14011","22019","30003"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"rabbit polyclonal. Antibody Target: H3K27ac","antibody targetdescription":"Histone H3 (acetyl K27). As with H3K9ac, associated with transcriptional initiation and open chromatin structure. It remains unknown whether acetylation has can have different consequences depending on the specific lysine residue targeted. In general, though, there appears to be high redundancy. Histone acetylation is notable for susceptibility to small molecules and drugs that target histone deacetylases.","antibody vendorname":"Abcam","antibody vendorid":"ab4729","controlid":"A549/EtOH_0.02pct/Input/std","replicate":"1,2","softwareversion":"ScriptureVPaperR3","cell sex":"M","antibody":"H3K27ac","treatment":"EtOH_0.02pct","treatment description":"1 h with 0.02% Ethanol (Myers)","control":"std","control description":"Standard input signal for most experiments.","labversion":"Illumina_HiSeq_2000","labversion description":"Illumina HiSeq 2000","original_filename":"GSM1003578_hg19_wgEncodeBroadHistoneA549H3k27acEtoh02Sig.bigWig"},"geolst":["GSM1003578"]},{"type":"bigWig","name":"Broad ChipSeq A549 H3K27me3","url":"http://egg.wustl.edu/d/hg19/GSM1003455_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":180,"pg":0,"pb":0,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14011","22018","30003"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"rabbit polyclonal. Antibody Target: H3K27me3","antibody targetdescription":"Histone H3 (tri-methyl K27). Marks promoters that are silenced by Polycomb proteins in a given lineage","antibody vendorname":"Millipore","antibody vendorid":"07-449","controlid":"A549/EtOH_0.02pct/Input/std","replicate":"1,2","softwareversion":"ScriptureVPaperR3","cell sex":"M","antibody":"H3K27me3","treatment":"EtOH_0.02pct","treatment description":"1 h with 0.02% Ethanol (Myers)","control":"std","control description":"Standard input signal for most experiments.","labversion":"Illumina_HiSeq_2000","labversion description":"Illumina HiSeq 2000","original_filename":"GSM1003455_hg19_wgEncodeBroadHistoneA549H3k27me3Etoh02Sig.bigWig"},"geolst":["GSM1003455"]},{"type":"bigWig","name":"UW ChipSeq Caco-2 Input","url":"http://egg.wustl.edu/d/hg19/GSM945236_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":200,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14004","22001","30004"],"details":{"lab":"UW","lab description":"Stamatoyannopoulous - University of Washington","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"Caco-2","cell organism":"human","cell description":"colorectal adenocarcinoma. (PMID: 1939345)","cell karyotype":"cancer","cell lineage":"endoderm","cell sex":"M","antibody":"Input","antibody description":"Control signal which may be subtracted from experimental raw signal before peaks are called.","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000454","labexpid":"DS13597","labversion":"Bowtie 0.12.5","replicate":"1","original_filename":"GSM945236_hg19_wgEncodeUwHistoneCaco2InputStdRawRep1.bigWig"},"geolst":["GSM945236"]},{"type":"bigWig","name":"UW ChipSeq Caco-2 H3K27me3","url":"http://egg.wustl.edu/d/hg19/GSM945203_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":180,"pg":0,"pb":0,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14004","22018","30004"],"details":{"lab":"UW","lab description":"Stamatoyannopoulous - University of Washington","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"Caco-2","cell organism":"human","cell description":"colorectal adenocarcinoma. (PMID: 1939345)","cell karyotype":"cancer","cell lineage":"endoderm","cell sex":"M","antibody":"H3K27me3","antibody antibodydescription":"rabbit polyclonal. Antibody Target: H3K27me3","antibody targetdescription":"Histone H3 (tri-methyl K27). Marks promoters that are silenced by Polycomb proteins in a given lineage","antibody vendorname":"Millipore","antibody vendorid":"07-449","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000454","labexpid":"DS12221","labversion":"Bowtie 0.12.5","replicate":"1","original_filename":"GSM945203_hg19_wgEncodeUwHistoneCaco2H3k27me3StdRawRep1.bigWig"},"geolst":["GSM945203"]},{"type":"bigWig","name":"UW ChipSeq Caco-2 H3K4me3","url":"http://egg.wustl.edu/d/hg19/GSM945162_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":117,"pb":0,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14004","22009","30004"],"details":{"lab":"UW","lab description":"Stamatoyannopoulous - University of Washington","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"Caco-2","cell organism":"human","cell description":"colorectal adenocarcinoma. (PMID: 1939345)","cell karyotype":"cancer","cell lineage":"endoderm","cell sex":"M","antibody":"H3K4me3","antibody antibodydescription":"rabbit polyclonal. Antibody Target: H3K4me3","antibody targetdescription":"Histone H3 (tri methyl K4). Marks promoters that are active or poised to be activated.","antibody vendorname":"Millipore","antibody vendorid":"07-473","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000454","labexpid":"DS11784","labversion":"Bowtie 0.12.5","replicate":"1","original_filename":"GSM945162_hg19_wgEncodeUwHistoneCaco2H3k4me3StdRawRep2.bigWig"},"geolst":["GSM945162"]},{"type":"bigWig","name":"Bernstein HeLa-S3 H3K4me3","url":"http://egg.wustl.edu/d/hg19/GSM733682_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":117,"pb":0,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14001","22009","30003"],"details":{"cell":"HeLa-S3","cell organism":"Human","cell description":"cervical carcinoma","cell karyotype":"cancer","cell lineage":"ectoderm","cell sex":"F","antibody":"H3K4me3","antibody description":"rabbit polyclonal","antibody target description":"Histone H3 (tri methyl K4). Marks promoters that are active or poised to be activated.","antibody vendor name":"Millipore","original_filename":"GSM733682_hg19_wgEncodeBroadHistoneHelas3H3k4me3StdSig.bigWig"},"geolst":["GSM733682"]},{"type":"bigWig","name":"Bernstein HeLa-S3 H3K27ac","url":"http://egg.wustl.edu/d/hg19/GSM733684_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":150,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14001","22019","30003"],"details":{"cell":"HeLa-S3","cell organism":"Human","cell description":"cervical carcinoma","cell karyotype":"cancer","cell lineage":"ectoderm","cell sex":"F","antibody":"H3K27ac","antibody description":"rabbit polyclonal","antibody target description":"Histone H3 (acetyl K27). As with H3K9ac, associated with transcriptional initiation and open chromatin structure. It remains unknown whether acetylation has can have different consequences depending on the specific lysine residue targeted. In general, though, there appears to be high redundancy. Histone acetylation is notable for susceptibility to small molecules and drugs that target histone deacetylases.","antibody vendor name":"Abcam","original_filename":"GSM733684_hg19_wgEncodeBroadHistoneHelas3H3k27acStdSig.bigWig"},"geolst":["GSM733684"]},{"type":"bigWig","name":"Broad ChipSeq HeLa-S3 EZH2","url":"http://egg.wustl.edu/d/hg19/GSM1003520_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14001","22060","30003"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"This EZH2 antibody was raised against a recombinant protein corresponding to amino acids 353-451 of human EZH2. Antibody Target: EZH2","antibody targetdescription":"EZH2 (Enhancer of Zeste homolog 2, also designated Enx1 and SETDB1) is a human homolog of the Drosophila Polycomb-group protein Enhancer of Zeste protein. It contains a SET domain that catalyzes the methylation of histone H3 at lysine 27 (Histone H3 Lys27 monomethylated, dimethylated and trimethylated). Polycomb-group proteins repress gene expression by binding to chromatin and locally altering chromatin structure. EZH2, BMI-1 and Suz12 are present in the PRC2 and PRC3 protein complexes that function as mediators of epigenetic transcriptional silencing. EZH2 associates with the embryonic ectoderm development protein, the VAV1 oncoprotein, and the X-linked nuclear protein. EZH2 may play a role in the hematopoietic and central nervous systems. Deregulation of EZH2 is linked to a variety of cancers.","antibody vendorname":"Active Motif","antibody vendorid":"39875","controlid":"HeLa-S3/None/Input/std","replicate":"1,2","softwareversion":"ScriptureVPaperR3","cell sex":"F","antibody":"EZH2_(39875)","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","labversion":"Illumina_HiSeq_2000","labversion description":"Illumina HiSeq 2000","original_filename":"GSM1003520_hg19_wgEncodeBroadHistoneHelas3Ezh239875Sig.bigWig"},"geolst":["GSM1003520"]},{"type":"bigWig","name":"UW ChipSeq HeLa-S3 H3K27me3","url":"http://egg.wustl.edu/d/hg19/GSM945208_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":180,"pg":0,"pb":0,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14001","22018","30004"],"details":{"lab":"UW","lab description":"Stamatoyannopoulous - University of Washington","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"HeLa-S3","cell organism":"human","cell description":"cervical carcinoma","cell karyotype":"cancer","cell lineage":"ectoderm","cell sex":"F","antibody":"H3K27me3","antibody antibodydescription":"rabbit polyclonal. Antibody Target: H3K27me3","antibody targetdescription":"Histone H3 (tri-methyl K27). Marks promoters that are silenced by Polycomb proteins in a given lineage","antibody vendorname":"Millipore","antibody vendorid":"07-449","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000469","labexpid":"DS12072","labversion":"Bowtie 0.12.5","replicate":"1","original_filename":"GSM945208_hg19_wgEncodeUwHistoneHelas3H3k27me3StdRawRep2.bigWig"},"geolst":["GSM945208"]},{"type":"bigWig","name":"UW ChipSeq HeLa-S3 H3K4me3","url":"http://egg.wustl.edu/d/hg19/GSM945201_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":117,"pb":0,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14001","22009","30004"],"details":{"lab":"UW","lab description":"Stamatoyannopoulous - University of Washington","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"HeLa-S3","cell organism":"human","cell description":"cervical carcinoma","cell karyotype":"cancer","cell lineage":"ectoderm","cell sex":"F","antibody":"H3K4me3","antibody antibodydescription":"rabbit polyclonal. Antibody Target: H3K4me3","antibody targetdescription":"Histone H3 (tri methyl K4). Marks promoters that are active or poised to be activated.","antibody vendorname":"Millipore","antibody vendorid":"07-473","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000469","labexpid":"DS11555","labversion":"Bowtie 0.12.5","replicate":"1","original_filename":"GSM945201_hg19_wgEncodeUwHistoneHelas3H3k4me3StdRawRep1.bigWig"},"geolst":["GSM945201"]},{"type":"bigWig","name":"UW ChipSeq HeLa-S3 Input","url":"http://egg.wustl.edu/d/hg19/GSM945253_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":200,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14001","22001","30004"],"details":{"lab":"UW","lab description":"Stamatoyannopoulous - University of Washington","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"HeLa-S3","cell organism":"human","cell description":"cervical carcinoma","cell karyotype":"cancer","cell lineage":"ectoderm","cell sex":"F","antibody":"Input","antibody description":"Control signal which may be subtracted from experimental raw signal before peaks are called.","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000469","labexpid":"DS11540","labversion":"Bowtie 0.12.5","replicate":"1","original_filename":"GSM945253_hg19_wgEncodeUwHistoneHelas3InputStdRawRep1.bigWig"},"geolst":["GSM945253"]},{"type":"bigWig","name":"USC ChipSeq NT2-D1 H3K4me3B","url":"http://egg.wustl.edu/d/hg19/GSM788072_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14002","22031","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"NT2-D1","cell organism":"human","cell description":"malignant pluripotent embryonal carcinoma (Ntera2), The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line. - ATCC. (PMID: 6694356)","cell karyotype":"cancer","cell lineage":"inner cell mass","cell sex":"M","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"H3K4me3B","antibody antibodydescription":"Rabbit monoclonal antibody","antibody targetdescription":"Histone H3 (tri-methyl K4) marks promoters in chromatin regions","antibody vendorname":"Cell Signaling","antibody vendorid":"9751S","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000654","replicate":"1","replicate description":"tier 1","original_filename":"GSM788072_wgEncodeSydhHistoneNt2d1H3k4me3bUcdSig.bigWig"},"geolst":["GSM788072"]},{"type":"bigWig","name":"USC ChipSeq NT2-D1 H3K27me3B","url":"http://egg.wustl.edu/d/hg19/GSM788071_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14002","22030","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"NT2-D1","cell organism":"human","cell description":"malignant pluripotent embryonal carcinoma (Ntera2), The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line. - ATCC. (PMID: 6694356)","cell karyotype":"cancer","cell lineage":"inner cell mass","cell sex":"M","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"H3K27me3B","antibody antibodydescription":"rabbit monoclonal","antibody targetdescription":"Histone H3 (tri-methyl K27) marks repressed chromatin regions","antibody vendorname":"Cell Signaling","antibody vendorid":"9733S","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000654","replicate":"1","replicate description":"tier 1","original_filename":"GSM788071_wgEncodeSydhHistoneNt2d1H3k27me3bUcdSig.bigWig"},"geolst":["GSM788071"]},{"type":"bigWig","name":"USC ChipSeq NT2-D1 Input","url":"http://egg.wustl.edu/d/hg19/GSM788077_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":200,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":0,"thmin":0,"thmax":10,"thpercentile":90,"height":10,"summeth":1},"annotation":["14002","22001","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"NT2-D1","cell organism":"human","cell description":"malignant pluripotent embryonal carcinoma (Ntera2), The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line. - ATCC. (PMID: 6694356)","cell karyotype":"cancer","cell lineage":"inner cell mass","cell sex":"M","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Input","antibody description":"Control signal which may be subtracted from experimental raw signal before peaks are called.","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000654","original_filename":"GSM788077_wgEncodeSydhHistoneNt2d1InputUcdSig.bigWig"},"geolst":["GSM788077"]},{"type":"native_track","list":[{"name":"refGene","mode":3,"qtc":{"anglescale":1,"pr":0,"pg":77,"pb":0,"nr":0,"ng":0,"nb":230,"pth":"#800000","nth":"#000099","thtype":0,"thmin":0,"thmax":10,"thpercentile":95,"height":50,"summeth":1,"textcolor":"rgb(0,0,0)","fontsize":"8pt","fontfamily":"sans-serif","fontbold":false,"bedcolor":"rgb(0,77,153)"}}]},{"type":"coordinate_override","coord":"chr3,187078190,chr3,187097343"},{"type":"native_metadata_terms","list":["Assay","Sample"]}]